LEGN Overview
Upcoming Projects (LEGN)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (LEGN)
-
Discussing the data from the CARTITUDE-4 Trial of Legend's CARVYKTI (ciltacabtagene autoleucel) in multiple myeloma
Ticker: LEGN
Executed On: Jul 24, 2024 at 09:00 AM EDT -
Discussing various agents targeting BCMA and GPRC5D in multiple myeloma
Tickers: JNJ, LEGN, BMY
Executed On: Jul 12, 2023 at 06:00 PM EDT
Expired Projects (LEGN)
-
Discussing the clinical landscape of multiple myeloma with a focus on BCMA CAR-T
Tickers: LEGN, JNJ, TSVT, BMY
Execute By: Oct 31, 2023 -
Discussing recent advancements in dermatology, with a focus on AD and psoriasis
Tickers: LEGN, BMY, JNJ
Execute By: Oct 27, 2023 -
Discussing various modalities for BCMA targeted therapy in multiple myeloma
Tickers: JNJ, LEGN, BMY
Execute By: Oct 27, 2023
Upcoming & Overdue Catalysts (LEGN)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (LEGN)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
